<The> effects of lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-A levels in patients with type 2 diabetes mellitus: a randomized controlled trial

Leila, Khalili; Beitullah, Alipour; Mohammad, Jafar Abadi; Ismail, Faraji; Tohid, Hassanalilou; Mehran, Abbasi; Elnaz, Vaghef Mehrabany; Mahmood, Sani

effects of lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-A levels in patients with type 2 diabetes mellitus: a randomized controlled trial

Leila, Khalili; Beitullah, Alipour; Mohammad, Jafar Abadi; Ismail, Faraji; Tohid, Hassanalilou; Mehran, Abbasi; Elnaz, Vaghef Mehrabany; Mahmood, Sani.

IBJ-Iranian Biomedical Journal. 2019; 23 (1): 68-77

in English | IMEMR | ID: emr-202863

ABSTRACT

ABSTRACT

Background:

Type 2 diabetes mellitus [T2DM] is related to the gut microbiota with numerous molecular mechanisms. Modulating the gut microbiota by probiotics could be effective in management of T2DM. The aim of the present trial was to evaluate the effect of Lactobacillus casei on glycemic control and serum sirtuin1 [SIRT1] and fetuin-A in patients with T2DM

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Type of study: Controlled clinical trial Language: English Journal: Iran. Biomed. J. Year: 2019

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Type of study: Controlled clinical trial Language: English Journal: Iran. Biomed. J. Year: 2019